News

Catalyze Capital invests in Beye Therapeutics

29 September 2026

Catalyze Capital invests in Melt&Marble

8 December 2025

Neuro Event Labs receives FDA 510(k) clearance

26 November 2025

Catalyze Capital invests in Neuro Event Labs

12 February 2025

Catalyze Capital invests in Gesynta Pharma

20 January 2025

Catalyze Capital announces first closing

2 April 2024